# Locus Biosciences Inc.

Canonical: https://abierto.us/vendors/locus-biosciences-inc-cjkvlkzgx6f3

- UEI: CJKVLKZGX6F3
- CAGE: 7H2T2
- Location: Morrisville, NC
- Awards in window: 2 (8 transactions), $56,722,165 obligated, January 19, 2024 to August 26, 2026

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 1 awards, $48,826,300
- National Institutes of Health: 1 awards, $7,895,865

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $56,722,165

## Competition

- Full and Open Competition: 2 awards

## Largest awards

- 75A50120C00169 (definitive contract): $48,826,300, Barda - Aspr / Daappo / Barda DCMA. The Purposes of This Modification Are to 1. Exercise Option Period 1 Clin 0002 with a Period of Performance of January 19, 2024 to September 30, 2025. 2. Increase the Indirect Rate Caps as a Result of This Modification: 1. Funding in the Am. https://www.usaspending.gov/award/CONT_AWD_75A50120C00169_7505_-NONE-_-NONE-/
- 75N93025C00035 (definitive contract): $7,895,865, National Institutes of Health Niaid. Advance a Novel Therapeutic to a First-In-Human Clinical Study. https://www.usaspending.gov/award/CONT_AWD_75N93025C00035_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/locus-biosciences-inc-cjkvlkzgx6f3.